Skip to content

Clinical Trial of Blenderized Tube Feeds Varying in Viscosity

A Novel N-of-1 Randomized, Controlled, Clinical Trial to Assess the Effect of Blenderized Tube Feeds on Esophagogastric Physiology

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05417958
Enrollment
40
Registered
2022-06-14
Start date
2023-10-12
Completion date
2028-04-01
Last updated
2026-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Feeding Disorders

Brief summary

The investigators are conducting a 16 week multiple cross-over study (N-of-1 trial) comparing two blenderized tube feeds varying in viscosity in 40 children.

Interventions

OTHERExtremely thick blenderized tube feed

Commercial blenderized tube feed, not diluted

OTHERMildly thick blenderized tube feed

Commercial blenderized tube feed, diluted with ingredients contained in blend

Sponsors

Boston Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \> 1 year * \>90% of total calories via G-tube for \> 6 months * G-tube diameter ≥ 14 French * moderate severity of upper GI symptoms of nausea, bloating, postprandial fullness and early satiety defined as Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD) composite score \> 2 * anticipated stable GI-related medications for the duration of the study.

Exclusion criteria

* cystic fibrosis, primary ciliary dyskinesia, interstitial lung disease, bronchiolitis obliterans, or lung transplant * untreated malabsorptive intestinal disease (e.g. Crohn's disease, celiac disease) * Nissen fundoplication * use of non-standard enteral formulas (e.g. ketogenic formulas) for the management of metabolic, endocrine or neurologic rare diseases * allergy or intolerance to any component of the study diet * inability to tolerate bolus gastric feeds.

Design outcomes

Primary

MeasureTime frameDescription
Upper GI symptoms8 weeks of extremely vs. 8 weeks of mildly thick blends (multiple cross-over design)differences in daily parental rating of upper gastrointestinal symptoms from the validated Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD) between extremely and mildly thick blenderized tube feeds

Secondary

MeasureTime frameDescription
Gastrointestinal symptoms8 weeks of extremely vs. 8 weeks of mildly thick blends (multiple cross-over design)Pediatric Quality of Life Inventory (PedsQL) Gastrointestinal Symptoms Questionnaire, scale of 0 to 100, higher scores indicate less symptom burden
Pulmonary symptoms8 weeks of extremely vs. 8 weeks of mildly thick blends (multiple cross-over design)Pediatric Cough Questionnaire, score ranges from 0 to 25, higher scores indicate less symptom burden
Health care utilization8 weeks of extremely vs. 8 weeks of mildly thick blends (multiple cross-over design)frequency of hospital admissions
GI medication use8 weeks of extremely vs. 8 weeks of mildly thick blends (multiple cross-over design)% of participants requiring acid suppressive medication or GI motility agents such as cyproheptadine and erythromycin
Height8 weeks of extremely vs. 8 weeks of mildly thick blends (multiple cross-over design)height
Weight8 weeks of extremely vs. 8 weeks of mildly thick blends (multiple cross-over design)Weight or weight for length
Weight for height/body mass index (BMI)8 weeks of extremely vs. 8 weeks of mildly thick blends (multiple cross-over design)weight for height (children \< 2) or BMI (over 2 years of age)
number of patients with unplanned G-tube exchange8 weeks of extremely vs. 8 weeks of mildly thick blends (multiple cross-over design)
urine output adequacy8 weeks of extremely vs. 8 weeks of mildly thick blends (multiple cross-over design)frequency of urine output
rate of respiratory suctioning per day8 weeks of extremely vs. 8 weeks of mildly thick blends (multiple cross-over design)how often suctioning is required (e.g. number of times per day)
need for antibiotics for pneumonitis8 weeks of extremely vs. 8 weeks of mildly thick blends (multiple cross-over design)frequency of antibiotics prescribed for pulmonary indications

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 18, 2026